- Home
- ACXP vs CODX Comparison
ACXP vs CODX Comparison
Compare ACXP & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- CODX
- Stock Information
- Founded
- ACXP 2017
- CODX 2013
- Country
- ACXP United States
- CODX United States
- Employees
- ACXP N/A
- CODX N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- CODX Medical/Dental Instruments
- Sector
- ACXP Health Care
- CODX Health Care
- Exchange
- ACXP Nasdaq
- CODX Nasdaq
- Market Cap
- ACXP 9.1M
- CODX 9.8M
- IPO Year
- ACXP 2021
- CODX 2017
- Fundamental
- Price
- ACXP $4.70
- CODX $0.32
- Analyst Decision
- ACXP Strong Buy
- CODX Buy
- Analyst Count
- ACXP 3
- CODX 2
- Target Price
- ACXP $143.67
- CODX $5.50
- AVG Volume (30 Days)
- ACXP 66.2K
- CODX 5.4M
- Earning Date
- ACXP 08-12-2025
- CODX 08-14-2025
- Dividend Yield
- ACXP N/A
- CODX N/A
- EPS Growth
- ACXP N/A
- CODX N/A
- EPS
- ACXP N/A
- CODX N/A
- Revenue
- ACXP N/A
- CODX $1,003,653.00
- Revenue This Year
- ACXP N/A
- CODX N/A
- Revenue Next Year
- ACXP N/A
- CODX $42.11
- P/E Ratio
- ACXP N/A
- CODX N/A
- Revenue Growth
- ACXP N/A
- CODX N/A
- 52 Week Low
- ACXP $3.80
- CODX $0.23
- 52 Week High
- ACXP $47.80
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- ACXP 33.75
- CODX 63.56
- Support Level
- ACXP $4.40
- CODX $0.28
- Resistance Level
- ACXP $5.29
- CODX $0.38
- Average True Range (ATR)
- ACXP 0.51
- CODX 0.03
- MACD
- ACXP 0.08
- CODX 0.01
- Stochastic Oscillator
- ACXP 40.91
- CODX 55.47
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.